Mario Sechi
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Virology top 2%
- HIV Research and Treatment
Papers in
-
- Enzyme function and inhibition 7
-
- Synthesis and Catalytic Reactions 7
- Co-authors
- Vanna Sanna (34 shared papers)Nicolino Pala (31 shared papers)Hasan Mukhtar (16 shared papers)Imtiaz A. Siddiqui (11 shared papers)Dominga Rogolino (23 shared papers)Alberto Mariani (13 shared papers)Nouri Neamati (20 shared papers)Mauro Carcelli (22 shared papers)
- Journals
- Journal of Medicinal Chemistry (8 papers)ACS Medicinal Chemistry Letters (7 papers)Molecular Pharmaceutics (4 papers)Cancer Research (4 papers)International Journal of Nanomedicine (4 papers)
- Partner nations
- ItalyUnited StatesBelgium
In The Last Decade
Mario Sechi
95 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 132
- Biomaterials 739
- Virology 227
- Geriatrics and Gerontology 160
- Molecular Medicine 228
- Pharmaceutical Science 210
Countries citing papers authored by Mario Sechi
This map shows the geographic impact of Mario Sechi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Sechi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Sechi more than expected).
Fields of papers citing papers by Mario Sechi
This network shows the impact of papers produced by Mario Sechi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Sechi. The network helps show where Mario Sechi may publish in the future.
Co-authors
The 25 scholars most cited alongside Mario Sechi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 383 | |
| 2 | 2011 | 142 | |
| 3 | 2012 | 137 | |
| 4 | 2013 | 130 | |
| 5 | 2011 | 130 | |
| 6 | 2011 | 119 | |
| 7 | 2015 | 117 | |
| 8 | 2004 | 106 | |
| 9 | 2014 | 98 | |
| 10 | 2014 | 93 | |
| 11 | 2017 | 91 | |
| 12 | 2006 | 75 | |
| 13 | 2016 | 74 | |
| 14 | 2012 | 72 | |
| 15 | 2016 | 69 | |
| 16 | 2013 | 69 | |
| 17 | 2011 | 66 | |
| 18 | 2013 | 63 | |
| 19 | 2015 | 62 | |
| 20 | 2016 | 62 |
About Mario Sechi
Mario Sechi is a scholar working on Molecular Biology, Organic Chemistry, Infectious Diseases, Epidemiology and Biomaterials, having authored 96 papers that have together received 4.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (22 papers), HIV Research and Treatment (12 papers), Nanoparticle-Based Drug Delivery (12 papers), Flavonoids in Medical Research (8 papers), Nanoplatforms for cancer theranostics (8 papers), Influenza Virus Research Studies (7 papers), Enzyme function and inhibition (7 papers) and Synthesis and Catalytic Reactions (7 papers). The work is most often cited by research in Biomaterials (739 citations), Virology (227 citations), Geriatrics and Gerontology (160 citations), Molecular Medicine (228 citations) and Pharmaceutical Science (210 citations). Mario Sechi has collaborated with scholars based in Italy, United States and Belgium. Frequent co-authors include Vanna Sanna, Nicolino Pala, Hasan Mukhtar, Imtiaz A. Siddiqui, Dominga Rogolino, Alberto Mariani, Nouri Neamati, Mauro Carcelli, Salvatore Marceddu and Anna Maria Roggio. Their work appears in journals such as Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, Molecular Pharmaceutics, Cancer Research and International Journal of Nanomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.